+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acorda Therapeutics Inc - logo

Acorda Therapeutics is a biopharmaceutical company that identifies, develops, and commercializes novel therapies for neurological disorders in the United States. It specializes in drugs that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Its best known products are Zanaflex, Ampyra and Qutenza. Acorda Therapeutics was founded in 1995 and is headquartered in Ardsley, New York.

From
Neurologic Disorders Therapeutics Market 2024-2028 - Product Thumbnail Image

Neurologic Disorders Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 150 Pages
  • Global
From
From
From
Spinal Cord Injury - Pipeline Insight, 2024 - Product Thumbnail Image

Spinal Cord Injury - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Multiple Sclerosis Drugs Global Market Report 2024 - Product Thumbnail Image

Multiple Sclerosis Drugs Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Spinal Cord Injury Market Report and Forecast 2024-2032 - Product Thumbnail Image

Spinal Cord Injury Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Ataxia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Ataxia Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Botulinum Toxin Market Report and Forecast 2023-2031 - Product Thumbnail Image

Botulinum Toxin Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Intranasal Drug Delivery - Global Strategic Business Report - Product Thumbnail Image

Intranasal Drug Delivery - Global Strategic Business Report

  • Report
  • January 2025
  • 459 Pages
  • Global
From
From
Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1400 Pages
  • Global
From
From
Loading Indicator